UBS Group’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Buy |
|
|||||
|
2025
Q1 | $215 | Sell |
|
|||||
|
2024
Q4 | $330 | Buy |
|
|||||
|
2024
Q3 | $64 | Sell |
|
|||||
|
2024
Q2 | $2.65K | Sell |
|
|||||
|
2024
Q1 | $7.82K | Sell |
|
|||||
|
2023
Q4 | $21.5K | Buy |
|
|||||
|
2023
Q3 | $315 | Sell |
|
|||||
|
2023
Q2 | $1.33K | Sell |
|
|||||
|
2023
Q1 | $12.3K | Buy |
|
|||||
|
2022
Q4 | $433 | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $10K | Buy |
|
|||||
|
2022
Q1 | $11K | Sell |
|
|||||
|
2021
Q4 | $56K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $97K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $6K | Sell |
|
|||||
|
2020
Q3 | $5K | Sell |
|
|||||
|
2020
Q2 | $9K | Sell |
|
|||||
|
2020
Q1 | $22K | Buy |
|
|||||
|
2019
Q4 | $18K | Buy |
|
|||||
|
2019
Q3 | $16K | Sell |
|
|||||
|
2019
Q2 | $34K | Sell |
|
|||||
|
2019
Q1 | $42K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $13K | Hold |
|
|||||
|
2018
Q1 | $13K | Buy |
|